Resources

The Global Health Science and Practice Technical Exchange (GHTechX) took place virtually from April 21 - 24, 2021. The event is curated through a partnership between USAID, the George Washington University, and the Global Health: Science and Practice Journal. Our goal is to convene speakers and technical sessions that highlight the latest and greatest in global health, with participants spanning global health experts, students, and professionals from across the global health community.

This webinar is part of a series of capacity-building webinars to enhance national NTD program supply chain competences and create space for cross-country experience sharing.

Cet évènement s’inscrit dans le cadre d’une série de webinaires de renforcement des capacités visant à améliorer les compétences nationales en matière de chaîne d’approvisionnement des programmes de MTN et à créer un espace de partage d’expérience entre pays.

Les effets indésirables (EI) particulièrement les effets indésirables graves (EIG) associés à l’administration de médicaments de masse ont un impact grave non seulement sur les personnes directement touchées, mais aussi sur la viabilité du programme national de lutte contre les maladies tropicales négligées (MTN) du ministère de la Santé.

Adverse events (AEs) particularly severe adverse events (SAEs) during and following mass drug administration have a serious effect not only on the people who are affected directly, but also on the viability of the MOH’s national NTD control program.

Trachoma baseline surveys, trachoma impact surveys, trachoma surveillance surveys, and trichiasis-only surveys are key disease-specific assessments of trachoma elimination programs, used to start mass drug administration (MDA), monitor progress, decide when to stop MDA, and inform attainment of elimination of trachoma as a public health problem.

This report outlines the key achievements and challenges in the first six months of the second year of implementation of USAID's Act to End NTDs | West Program, spanning the period October 1, 2019–March 31, 2020.

This resource document complements the World Health Organization’s (WHO’s) guidance for NTD programs released on July 27, 2020.

Cette brochure résume le travail de la loi de l'USAID pour mettre fin aux MTN | Programme Ouest, qui donne une vue d’ensemble des activités du programme et des progrès accomplis à ce jour alors que nous continuons à prendre des mesures pour perturber les dommages causés par les maladies débilitantes de la pauvreté. Construit sur la base d'une large coopération internationale et mis en œuvre par un consortium solide de partenaires profondément engagés, dirigé par FHI 360, Act | West travaille en étroite collaboration avec les gouvernements de 11 pays africains pour éliminer et contrôler à long terme cinq des MTN les plus courantes au monde.

This brochure summarizes the work of USAID's Act to End NTDs | West Program, providing a big picture look at program activities and progress to date as we continue taking action to disrupt the damage of debilitating diseases of poverty. Built on a foundation of broad international cooperation and implemented by a strong consortium of deeply committed partners, led by FHI 360, Act | West works closely with the governments of 11 African countries to eliminate and control five of the world’s most common NTDs over the long term.